Table 1.
Upregulated acute-phase proteins used as inflammatory biomarkers.
| Acute phase protein | Main role | Normal range | Time after inflammatory stimulus (in hours) | Maximum fold change in plasma concentration |
|---|---|---|---|---|
| CRP (C-reactive protein) | Binding to pathogens and damaged cells, opsonin, complement activation | < 0.5 mg/L | 6-12 h | x 1000 |
| PCT (procalcitonin) | Unknown | < 10 pg/mL | 6- 8 h | x 400-1000 |
| SAA (Serum amyloid A) | Opsonin, regulation of innate defense, induction of extracellular matrix degrading enzymes, chemoattractant, apolipoprotein with HDL, regulation of lipid metabolism | < 10 mg/L | 6-12 h | x 1000 |
| α1-glycoprotein (or orosomucoid) | Binding of plasma proteins and mediators, chaperone, regulation of innate defense | < 1.5 g/L | 12 h | x 2-4 |
| Haptoglobin | Scavenging of hemoglobin, antioxidants, angiogenesis, chaperone | 0.5-2 g/L | 12 h | x 2-4 |
| Fibrinogen | Clot formation | 2-4 g/L | 12 h | x 2-4 |
| AAT (α1-anti trypsin) | Enzyme inhibition | 2-4 g/L | 12 h | x 2-4 |
| C3 complement | Pathogen recognition, destruction, chemotaxis, opsonin, vasoregulation | 0.8 à 18 g/L | 48 h | x 1.5 |
| Ceruloplasmin | Iron and copper homeostasis | 0.2-0.6 g/L | 48 h | x 1.5 |